Compare Agilent Technologies Inc (A) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Global X Uranium ETF — how do they compare? Agilent Technologies Inc trades at $148.37 (market cap $42.22B), while Global X Uranium ETF trades at $45.32. The key difference: Agilent Technologies Inc pays a 0.68% dividend while Global X Uranium ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| A | URA | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $157.20 | $61.81 |
52-Week Low | $110.24 | $36.45 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.
URA, the Global X Uranium ETF, trades at $45.63, up 2.82% with a bullish technical signal from moving averages. The ETF benefits from strong policy support including $17.5 billion in federal nuclear funding and growing AI power demand. Recent index additions like Terra Innovatum and Eagle Nuclear Energy expand exposure to nuclear supply chain companies. RSI_6 at 92.76 indicates potential short-term overbought conditions while ADX signals strong trend momentum.
The uranium sector outlook remains positive with nuclear energy positioned as a solution to AI power demands and global energy security needs. Key risks include ETF concentration in uranium miners and sensitivity to commodity price volatility. Support at $45 and resistance at $46 will be critical for near-term price direction as the sector capitalizes on nuclear renaissance tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
